The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...
From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback